Univercells Tech
Articles
Gene Therapy Manufacturing: A Dual Platform Reconciling Adherence and Suspension Approaches
July 15th 2021Thursday, July 15, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST What adherence and suspension-based technologies are best for gene therapy production? In this webinar, learn about a next-generation dual platform solution for viral vector manufacturing that helps to overcome existing barriers to scaling and commercializing gene therapies.
Latest Updated Articles
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: November 22nd 2024 | Updated: November 26th 2024
The Pharmacy Advantage in Direct-to-Patient Clinical Supply
Published: October 28th 2024 | Updated: November 26th 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 15th 2024 | Updated: November 26th 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Published: October 28th 2024 | Updated: November 26th 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
